A B S T R A CT COOH-terminal octapeptide of cholecystokinin (CCK-octapeptide) 
INTRODUCTION
The peptide hormone cholecystokinin (CCK)', as well as cholinergic agents such as acetylcholine and carbamyl-peptide.
choline, are known to stimulate enzyme secretion from the pancreas in vivo, in situ, and in vitro (1) (2) (3) . Although the sequence of morphologic changes attending pancreatic enzyme secretion has been characterized (4), the coincident sequence of biochemical events is poorly understood and the mechanism by which CCK and cholinergic agents initiate pancreatic secretion has not been characterized. Some investigators (5) (6) (7) (8) (9) (10) have suggested that stimulation of cellular accumulation of adenosine 3',5'-cyclic monophosphate (cyclic AMP) is involved in stimulation of pancreatic enzyme secretion, while others (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) have focused on changes in membrane transport of cations, in general, and of calcium in particular.
A major requirement for elucidating the biochemical mechanism of action of pancreatic secretagogues is a homogeneous preparation of isolated pancreatic cells that maintain their viability and hormone responsiveness in vitro for a sufficient period of time. Amsterdam and Jamieson (23) have reported a technique for preparing viable, isolated acinar cells from guinea pig pancreas that respond to secretagogues in vitro for several hours. In the present studies we have used isolated acinar cells from guinea pig pancreas to explore the kinetics, stoichiometry, and chemical specificity with which CCK and carbamylcholine alter membrane transport of calcium, in an effort to better understand the mechanism of action of these secretagogues and to establish a basis for directly evaluating hormone receptor interaction as well as for exploring the role of calcium in pancreatic enzyme secretion. Div ., Becton, Dickinson & Co., Orangeburg, N. Y.; pentagastrin (Peptavlon) from Ayerst Laboratories, New York; and porcine glucagon from Eli Lilly and Company, Indianapolis, Ind. Natural porcine secretin, natural porcine vasoactive intestinal peptide (VIP), and natural porcine CCK were gifts from Prof. Viktor Mutt, GIH Research Unit, Karolinska Institutet, Stockholm, Sweden. Prostaglandin E1 was a gift from Dr. John Pike, The Upjohn Company, Kalamazoo, Mich. Crude collagenase (Clostridium histolyticum, EC 3.4.4.19) and crude bovine-testis hyaluronidase (EC 3.2.1.35) were purchased from Sigma Chemical Co., St. Louis, Mo., and chromatographically purified soybean trypsin inhibitor was purchased from Worthington Biochemical Corp., Freehold, N. J. Bovine plasma albumin, fraction V, was purchased from Miles Laboratories, Inc., Elkhart, Ind. All other reagents were of the highest grade commercially obtainable.
Tissue preparation. After an overnight fast, animals were killed by cervical dislocation. The pancreas was dissected free of fat and mesentery, and isolated pancreatic exocrine cells were prepared by the procedure of Amsterdam and Jamieson (23) . Cells were isolated by incubating one pancreas (0.8 g of tissue) in a Krebs-Ringer bicarbonate buffer (pH 7.4), equilibrated with 95%o 02 and 5%o C02, and containing L-amino acid supplement (24), 0.1 mg/ml soybean trypsin inhibitor, and 14 mM glucose. Crude collagenase and hyaluronidase, MgC12, CaCl2, and disodium EDTA were added as previously described (23) . The tissue was incubated at 37'C in a Dubnoff shaking metabolic incubator (130 oscillations/min). The entire isolation procedure required approximately 90 min from the time the animals were sacrificed. At the end of the incubation cells were liberated by passage through a Pasteur pipet five times. The cells were layered over Krebs-Ringer bicarbonate (pH 7.4) containing 4%o (wt/vol) albumin, 1.0 mM CaCl2, and centrifuged at 50 g for 5 min at 4'C. This procedure was repeated twice and then performed once with buffer containing 8%o albumin and 0.5 mM calcium. By light and electron microscopy more than 96% of the cells were zymogen-containing exocrine cells. Viability of these cells was demonstrated by their ability to exclude trypan blue, to incorporate L-[8H]leucine into cellular protein, and to maintain their cellular concentrations of sodium and potassium for up to 4 h. "Ca transport. Uptake of 'Ca by isolated guinea pig pancreatic acinar cells was determined with the technique used previously to measure transport of other substrates and ions in other isolated cell preparations (25) (26) (27) (28) (29) (30) . Pancreatic acinar cells (5-20 X 100 cells/ml) were incubated at 37'C in the standard buffer, Krebs-Ringer bicarbonate ( (31) . At some time during the incubation, 100 ,ul of the cell suspension were homogenized with 2.0 ml of 10 mM Tris C1 (pH 7.6) and amylase activity was determined on a sample of the lysate. Amylase release was expressed as the percent of the total amylase activity, as measured in the lysate, which appears in the incubation medium.
RESULTS
Uptake of 'Ca by isolated guinea pig pancreatic acinar cells was moderately rapid, and cellular 'Ca reached a steady state after 45 min of incubation (Fig. 1 ).
After addition of synthetic COOH-terminal octapeptide of CCK (CCK-octapeptide, 10 (Table I ). The inhibition of carbamylcholine-stimulated calcium outflux by atropine increased with increasing concentrations of atropine and decreased with increasing concentrations of carbamylcholine, indicating that atropine is a competitive inhibitor of carbamylcholine (Fig. 8) . In intact tissue preparations, atropine inhibits stimulation of amylase secretion and of calcium outflux by cholinergic agents but not that produced by CCK (2, 3) .
In isolated pancreatic acinar cells, we also found that atropine could abolish stimulation of calcium outflux by carbamylcholine but not that produced by CCK-octapeptide. Atropine, which alone does not alter calcium outflux, is a competitive inhibitor of carbamylcholine, and in pancreatic acinar cells the apparent affinity of the cholinergic receptor for atropine is 10,000 times greater than its apparent affinity for carbamylcholine. The ability of atropine to inhibit the effect of carbamylcholine but not that of CCK-octapeptide indicates that although each of these secretagogues stimulates the same calcium outflux mechanism, the receptors with which they interact to produce this effect are functionally distinct. Furthermore, the apparent affinity of CCKoctapeptide for its receptor was 105 greater than that of carbamylcholine for its receptor.
In (11, 12, 14, 15, 17, 18 (3, 37) . Thus, the NHF-terminal portion of the molecule, CCK1-=, reduces the potency of the biologically active COOH-terminal portion, perhaps by sterically hindering the interaction of the COOH-terminal portion with the CCK receptor. CCK-octapeptide, heptapeptide, CCK, hexapeptide, gastrin, and pentagastrin share a common COOH-terminal tetrapeptide amide that is absolutely required for stimulation of calcium outflux in pancreatic acinar cells. The NH2-terminal tetrapeptide amide of CCK-octapeptide, CCKns-2, at concentrations as high as 10' M failed to stimulate calcium outflux; therefore, this portion of the octapeptide molecule, inactive by itself, serves to enhance greatly (by 50,000-fold) the potency of the COOH-terminal tetrapeptide. Additional evidence for the importance of the COOH-terminal tetrapeptide portion of CCK-octapeptide for stimulating calcium outflux is that substituting alanine for the aspartic residue in position 32 reduced its potency by 500-fold and that replacing the methionine residue in position 31 by leucine produced a 100-fold reduction in potency of CCK-octapeptide. CCK-hexapeptide, gastrin I, gastrin II, and pentagastrin were each found not to inhibit CCKoctapeptide stimulation of calcium outflux. This finding appears to exclude the possibility that the COOH-terminal tetrapeptide of CCK-octapeptide is responsible for binding to the receptor and that the remaining amino acids are responsible for producing the biologic effect. Instead, the observed relative potencies appear to reflect the apparent affinities with which the various peptides bind to the CCK receptor on pancreatic acinar cells.
We found that changing the aspartic residue in position 26 to fi-aspartic resulted in a compound having the same potency as CCK-heptapeptide. In contrast, in terms of stimulating gallbladder contraction in vitro, the P-aspartic analog was two to four times more potent than CCK-octapeptide (3, 37) . BOC-CCK-octapeptide has been reported to be 30-60% less potent than CCK-octapeptide in stimulating gallbladder contraction (3, 37); however, we found this compound to be only 1% as potent as CCK-octapeptide in stimulating calcium outflux from pancreatic acinar cells. While f-aspartic CCK-octapeptide was equipotent with CCK-heptapeptide, BOC-CCK-octapeptide was 10 times less potent than the heptapeptide. These findings suggest that the BOC moiety may introduce a degree of steric hindrance or that a free NHF-terminal amino group is important for biologic potency.
In other systems a sulfated tyrosine residue has been found to be important but not essential for biologic activity of CCK or CCK-octapeptide (3, 37) . In terms of its potency for stimulating calcium outflux in pancreatic acinar cells, desulfated CCK-octapeptide was 1,000 times less potent than the sulfated peptide. We also found that the position of the sulfated tyrosine was important for biologic potency. Exchanging the sulfated tyrosine with the adjacent methionine reduced the potency of CCK-octapeptide by 1,000-fold. This analog has the same COOH-terminal six amino acids as does gastrin II but is 50 times more potent in stimulating calcium outflux. Finally, substituting leucine for both of the methionine residues in CCK-octapeptide results in a compound having the same potency as CCK-octapeptide with only the methionine in position 31 replaced by leucine, suggesting that the methionine in position 28 does not play a major role in determining the potency of CCK-octapeptide.
Secretin, glucagon, and VIP each (at concentrations from 10' to 10' M) failed to stimulate calcium outflux from pancreatic acinar cells. In contrast to observations that in vivo secretin can potentiate the stimulation of enzyme release produced by CCK (38-40), we found that secretin did not alter the stimulation of calcium outflux produced by CCK-octapeptide or by carbamylcholine.
